Al-Razi Medical Co. Announces the Results of the Extraordinary General Assembly Meeting (First Meeting)

Mr. Abdullah bin Nasser bin Ibrahim Al-Dujan - Vice Chairman of the Board of Directors.

Mr. Mohammed bin Abdullah bin Mohammed Al-Mousa - Member of the Board of Directors.

Mr. Abdulrahman bin Mohammed bin Abdullah Al-Suhaibani - Member of the Board of Directors.

Mr. Abdulmajeed bin Abdulrahman Al-Arini - Member of the Board of Directors.

B. Mohammed bin Abdullah bin Mohammed Al-Mousa - Chairman of the Remuneration and Nominations Committee.

2. The financial statements for the fiscal year ending December 31, 2024, were reviewed and discussed.

3. The auditor's report for the fiscal year ending December 31, 2024, was approved after discussion.

4. The appointment of Ibrahim Ahmed Al Bassam & Partners as the company's auditor, from among the candidates nominated by the Audit Committee, was approved. The auditors will review and audit the semi-annual and annual financial statements for the fiscal year 2025, at a fee of SAR 180,000, excluding value-added tax.

5. The Board of Directors was discharged from liability for the fiscal year ending December 31, 2025.

6. Approval of the Board of Directors' decision to appoint Mr. Abdulmajeed bin Abdulrahman Al-Arini as an independent member of the Board of Directors, effective from the date of his appointment on January 23, 2025, to complete the Board's term until the end of the current term on September 8, 2026. He succeeds the former member, Abdulaziz bin Abdullah Al-Oud, as an independent member. (CV attached.)

7. Approval of transferring the balance of the company's statutory reserve, which amounted to (561,323) five hundred and sixty-one thousand three hundred and twenty-three Saudi riyals, according to the annual financial statements ending December 31, 2024, to the balance of retained earnings.